Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers.

Najia MA, Jha DK, Zhang C, Laurent B, Kubaczka C, Markel A, Li C, Morris V, Tompkins A, Hensch L, Qin Y, Chapuy B, Huang YC, Morse M, Marunde MR, Vaidya A, Gillespie ZB, Howard SA, North TE, Dominguez D, Keogh MC, Schlaeger TM, Shi Y, Li H, Shipp MM, Blainey PC, Daley GQ

Open source

DOI: 10.1101/2025.01.31.635709
Published: 2025 Feb 5
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1101/2025.01.31.635709,
  title = {Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers.},
  author = {Najia MA and Jha DK and Zhang C and Laurent B and Kubaczka C and Markel A and Li C and Morris V and Tompkins A and Hensch L and Qin Y and Chapuy B and Huang YC and Morse M and Marunde MR and Vaidya A and Gillespie ZB and Howard SA and North TE and Dominguez D and Keogh MC and Schlaeger TM and Shi Y and Li H and Shipp MM and Blainey PC and Daley GQ},
  year = {2025},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.1101/2025.01.31.635709},
  url = {https://doi.org/10.1101/2025.01.31.635709}
}

RIS

TY  - JOUR
TI  - Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers.
AU  - Najia MA
AU  - Jha DK
AU  - Zhang C
AU  - Laurent B
AU  - Kubaczka C
AU  - Markel A
AU  - Li C
AU  - Morris V
AU  - Tompkins A
AU  - Hensch L
AU  - Qin Y
AU  - Chapuy B
AU  - Huang YC
AU  - Morse M
AU  - Marunde MR
AU  - Vaidya A
AU  - Gillespie ZB
AU  - Howard SA
AU  - North TE
AU  - Dominguez D
AU  - Keogh MC
AU  - Schlaeger TM
AU  - Shi Y
AU  - Li H
AU  - Shipp MM
AU  - Blainey PC
AU  - Daley GQ
PY  - 2025
JO  - bioRxiv : the preprint server for biology
DO  - 10.1101/2025.01.31.635709
UR  - https://doi.org/10.1101/2025.01.31.635709
ER  -

APA

MA, N., DK, J., C, Z., B, L., C, K., A, M., C, L., V, M., A, T., L, H., Y, Q., B, C., YC, H., M, M., MR, M., A, V., ZB, G., SA, H., TE, N., D, D., MC, K., TM, S., Y, S., H, L., MM, S., PC, B., & GQ, D. (2025). Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.01.31.635709

Source records

pubmed · retrieved 2026-09-26T17:07:03.862Z